Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye tracking reveals hidden clues in Kids' language delays

NCT ID NCT02609542

Knowledge-focused Sponsor: Lille Catholic University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study uses eye-tracking technology to see how children with language development disorders process and remember sounds compared to typically developing children. Researchers will track eye movements while children perform language tasks to understand how their brains handle verbal information. The goal is to find patterns that predict which children will outgrow their language difficulties and which may need long-term support.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help identify early signs of persistent language disorders and improve how we support children's language development.
What could go wrong
This is an observational study, not a treatment trial. It only measures abilities and does not test any therapy, so direct benefits are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

173 people

The number who actually took part.

Start date

Mar 2014

Finished

May 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

STOL children between 45 and 95 months of age at inclusion recruited at the neuropediatric consultation and control children of the same age recruited at schools

Ages

45 to 95 months

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for STOL patients: * Child aged between 45 and 95 months at inclusion * A score \> or equal to 5 percentile on the non verbal intelligence test (PM47) * Patient diagnosed with STOL by the neuropediatric medical team * Coverage of the social insurance * Consent form signed by the parents or the legal representative of the child * Normal or corrected sight * Normal hearing Inclusion Criteria for control patients: * Child aged between 45 and 95 months on the day of inclusion * A score \> or equal to 5 percentile on the non verbal intelligence test (PM47) * Child who did not receive any speech therapy * Coverage of the social insurance * Consent form signed by the parents or the legal representative of the child * Normal or corrected sight * Normal hearing Exclusion Criteria for STOL patients: * Mother language other than French * Score \< to 5 percentile on the non verbal intelligence test (PM47) * Child with pervasive developmental disorder Exclusion Criteria for control patients: * Mother language other than French * Score \< to 5 percentile on the non verbal intelligence test (PM47) * Child who received speech therapy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Language development disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Language Development Disorders language disorder specific language impairment

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Language development disorders

Contacts and locations

Locations

  • Hôpital St Vincent-de-Paul (GHICL)

    Lille, Hauts-de-France, 59000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.